SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Nature Chemical Biology

• Publication date

  2015-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nchembio.1837PMID 26030728
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The human splicing code reveals new insights into the genetic determinants of disease

  2015cited by this paper
• Crystal structure of human U1 snRNP, a small nuclear ribonucleoprotein particle, reveals the mechanism of 5′ splice site recognition

  2015cited by this paper
• Pharmacology of a Central Nervous System Delivered 2′-O-Methoxyethyl–Modified Survival of Motor Neuron Splicing Oligonucleotide in Mice and Nonhuman Primates

  2014cited by this paper
• SEC-TID

  2014cited by this paper
• Requirement of enhanced Survival Motoneuron protein imposed during neuromuscular junction maturation.

  2014cited by this paper
• A day in the life of the spliceosome

  2014cited by this paper
• SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy

  2014cited by this paper
• The missing puzzle piece: splicing mutations.

  2013cited by this paper
• Pick one, but be quick: 5' splice sites and the problems of too many choices.

  2013cited by this paper
• The Alternative Heart: Impact of Alternative Splicing in Heart Disease

  2013cited by this paper
• Targeting RNA-splicing for SMA treatment

  2012cited by this paper
• Characterization of behavioral and neuromuscular junction phenotypes in a novel allelic series of SMA mouse models.

  2012cited by this paper
• Fast gapped-read alignment with Bowtie 2

  2012cited by this paper
• ALiBERO: Evolving a Team of Complementary Pocket Conformations Rather than a Single Leader

  2012cited by this paper
• Spinal muscular atrophy: a timely review.

  2011cited by this paper
• SpliceDisease database: linking RNA splicing and disease

  2011cited by this paper
• Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72 400 specimens

  2011cited by this paper
• Temporal requirement for high SMN expression in SMA mice.

  2011cited by this paper
• Prediction of alternative isoforms from exon expression levels in RNA-Seq experiments

  2010cited by this paper
• MEME Suite: tools for motif discovery and searching

  2009cited by this paper
• An efficient and reversible transposable system for gene delivery and lineage-specific differentiation in human embryonic stem cells.

  2009cited by this paper
• A computational approach for genome-wide mapping of splicing factor binding sites

  2009cited by this paper
• Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling

  2009cited by this paper
• Splicing regulation: from a parts list of regulatory elements to an integrated splicing code.

  2008cited by this paper
• Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice.

  2008cited by this paper
• Alternative Isoform Regulation in Human Tissue Transcriptomes

  2008cited by this paper
• The MC-Fold and MC-Sym pipeline infers RNA structure from sequence data

  2008cited by this paper
• Spinal muscular atrophy.

  2008cited by this paper
• Regulation of SMN Protein Stability

  2008cited by this paper
• Binding of DAZAP1 and hnRNPA1/A2 to an Exonic Splicing Silencer in a Natural BRCA1 Exon 18 Mutant

  2008cited by this paper
• Identification of a battery of tests for drug candidate evaluation in the SMNDelta7 neonate model of spinal muscular atrophy.

  2008cited by this paper
• Molecular Mechanisms of Spinal Muscular Atrophy

  2007cited by this paper
• Enhancement of SMN2 Exon 7 Inclusion by Antisense Oligonucleotides Targeting the Exon

  2007cited by this paper
• Splicing factor SF3b as a target of the antitumor natural product pladienolide

  2007cited by this paper
• Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

  2007cited by this paper
• Modulating role of RNA structure in alternative splicing of a critical exon in the spinal muscular atrophy genes

  2006cited by this paper
• Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease.

  2005cited by this paper
• SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN.

  2005cited by this paper
• WebLogo: a sequence logo generator.

  2004cited by this paper
• NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins

  2004cited by this paper
• Maximum Entropy Modeling of Short Sequence Motifs with Applications to RNA Splicing Signals

  2003cited by this paper
• An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA

  2001cited by this paper
• Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels.

  2000cited by this paper
• A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2.

  1999cited by this paper
• Purification of U small nuclear ribonucleoprotein particles.

  1999cited by this paper
• A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy.

  1999cited by this paper
• Detection of the survival motor neuron (SMN) genes by FISH: further evidence for a role for SMN2 in the modulation of disease severity in SMA patients.

  1999cited by this paper
• Differential SMN2 expression associated with SMA severity

  1998cited by this paper
• Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number.

  1997cited by this paper
• Identification and characterization of a spinal muscular atrophy-determining gene

  1995cited by this paper
• Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins.

  1994cited by this paper
• Pre-mRNA splicing by complementation with purified human U1, U2, U4/U6 and U5 snRNPs.

  1988cited by this paper
• Normal and mutant human beta-globin pre-mRNAs are faithfully and efficiently spliced in vitro.

  1984cited by this paper

• Pathogenesis of polyglutamine diseases: Piecing together a complex molecular puzzle.

  2026cites this paper
• A review on RNA technologies renaissance: a paradigm shift shaping the future of modern medicine

  2026cites this paper
• Specificity and exon target space of splicing modifying compounds

  2026cites this paper
• Small molecule splicing modulators that disrupt O-GlcNAc homeostasis

  2026cites this paper
• Non-Cell-Autonomous Mechanisms and Systemic Interactions in Spinal Muscular Atrophy.

  2026cites this paper
• Predicting small molecule-RNA interactions without RNA tertiary structures.

  2026cites this paper
• Oral splicing modulator branaplam in Huntington’s disease: a phase 2 randomized controlled trial

  2026cites this paper
• RNA-binding proteins as therapeutic targets in cancer

  2025cites this paper
• Targeting RNA with small molecules using state-of-the-art methods provides highly predictive affinities of riboswitch inhibitors

  2025cites this paper
• RNA splicing modulator for Huntington’s disease treatment induces peripheral neuropathy

  2025cites this paper
• Catecholaminergic dysfunction drives postural and locomotor deficits in a mouse model of spinal muscular atrophy

  2025cites this paper
• MAPT Splicing Modulators as a Therapeutic Strategy for Tauopathies

  2025cites this paper
• Updates of spinal muscular atrophy in advanced therapies.

  2025cites this paper
• The Endo-GeneScreen platform identifies drug-like probes that regulate endogenous protein levels within physiological contexts

  2025cites this paper
• The Druggable Transcriptome Project: From Chemical Probes to Precision Medicines.

  2025cites this paper
• Machine Learning‐Augmented Molecular Dynamics Simulations (MD) Reveal Insights Into the Disconnect Between Affinity and Activation of ZTP Riboswitch Ligands

  2025cites this paper
• Proprioceptive synaptic dysfunction is a key feature in mice and humans with spinal muscular atrophy.

  2025cites this paper
• Poison exons: tuning RNA splicing for targeted gene regulation.

  2025cites this paper
• MGTbind: a comprehensive database of molecular glue ternary interactome

  2025cites this paper
• RNA localization to nuclear speckles follows splicing logic

  2025cites this paper
• Systematic characterization of existing and novel inducible transgenic systems in human pluripotent stem cells after prolonged differentiation

  2025cites this paper
• Load and lock: An emerging class of therapeutics that influence macromolecular dissociation.

  2025cites this paper
• Therapeutic targeting of mismatch repair proteins in triplet repeat expansion diseases.

  2025cites this paper
• Targeting RNA-binding proteins with small molecules: perspectives and challenges

  2025cites this paper
• Xist condensates: perspectives for therapeutic intervention

  2025cites this paper
• Splicing to keep splicing: A feedback system for cellular homeostasis and state transition

  2025cites this paper
• Risdiplam: A Small Molecule mRNA Splice Modifier Approved to Treat SMA Disease

  2025cites this paper
• Design of an orally bioavailable small molecule that modulates the microtubule-associated protein tau’s pre-mRNA splicing

  2025cites this paper
• The Endo-GeneScreen Platform Identifies Drug-Like Probes that Regulate Endogenous Protein Levels within Physiological Contexts

  2025cites this paper
• Docking and Molecular Dynamics Simulation‐Based Analysis of Advanced Small‐Molecule Kinase Inhibitors Identified pre‐let‐7 miRNA Binders

  2025cites this paper
• Genome-Wide Analysis of Stable RNA Secondary Structures across Multiple Organisms Using Chemical Probing Data: Insights into Short Structural Motifs and RNA-Targeting Therapeutics.

  2025cites this paper
• Targeting RNA binding proteins with small-molecule inhibitors: Advances, challenges, and therapeutic opportunities

  2025cites this paper
• The U1 snRNP protein U1C and Helix H of U1 snRNA are critical for small molecule splicing modulator function

  2025cites this paper
• Insights into the human pharmacokinetics and metabolism of branaplam, a splicing modulator of a survival motor neuron-2 and huntingtin pre-mRNAs, in infants and adults.

  2025cites this paper
• Heterobifunctional small molecules to modulate RNA function.

  2024cites this paper
• Latest advances on new promising molecular-based therapeutic approaches for Huntington’s disease

  2024cites this paper
• Small molecule inhibition of RNA binding proteins in haematologic cancer

  2024cites this paper
• Dysfunction of proprioceptive sensory synapses is a pathogenic event and therapeutic target in mice and humans with spinal muscular atrophy

  2024cites this paper
• Engineered Branaplam Aptamers Exploit Structural Elements from Natural Riboswitches

  2024cites this paper
• Machine learning-augmented molecular dynamics simulations (MD) reveal insights into the disconnect between affinity and activation of ZTP riboswitch ligands

  2024cites this paper
• Global impact of unproductive splicing on human gene expression

  2024cites this paper
• RNA and condensates: Disease implications and therapeutic opportunities.

  2024cites this paper
• Dynamic interactions drive early spliceosome assembly.

  2024cites this paper
• Timing of SMN replacement therapies in mouse models of spinal muscular atrophy: a systematic review and meta-analysis

  2024cites this paper
• A sequential binding mechanism for 5′ splice site recognition and modulation for the human U1 snRNP

  2024cites this paper
• Genome-Wide Identification of Stable RNA Secondary Structures Across Multiple Organisms Using Chemical Probing Data: Insights into Short Structural Motifs and RNA-Targeting Therapeutics

  2024cites this paper
• Splice-modifying drug mechanisms

  2024cites this paper
• Advances in gene and cellular therapeutic approaches for Huntington’s disease

  2024cites this paper
• Photoaffinity enabled transcriptome-wide identification of splice modulating small molecule–RNA binding events in native cells

  2024cites this paper
• Design and evaluation of antisense sequence length for modified mouse U7 small nuclear RNA to induce efficient pre-messenger RNA splicing modulation in vitro

  2024cites this paper
• Targeting RNA-protein interactions with small molecules: promise and therapeutic potential

  2024cites this paper
• Targeting RNA with small molecules, from RNA structures to precision medicines: IUPHAR review: 40

  2024cites this paper
• A compact, versatile drug-induced splicing switch system with minimal background expression

  2024cites this paper
• RNA-Binding Small Molecules in Drug Discovery and Delivery: An Overview from Fundamentals.

  2024cites this paper
• The diversity of splicing modifiers acting on A-1 bulged 5′-splice sites reveals rules for rational drug design

  2024influential citation
• Modulation of prion protein expression through cryptic splice site manipulation

  2024cites this paper
• Spinal Muscular Atrophy: Current Medications and Re-purposed Drugs

  2024cites this paper
• Emotions experienced by parents whose children have spinal muscular atrophy: A qualitative research.

  2024cites this paper
• Mechanistic studies of small molecule ligands selective to RNA single G bulges

  2024cites this paper
• A Sequential Binding Mechanism for 5’ Splice Site Recognition and Modulation for the Human U1 snRNP

  2024cites this paper
• RNA-Small-Molecule Interaction: Challenging the "Undruggable" Tag.

  2024cites this paper
• Specificity, synergy, and mechanisms of splice-modifying drugs

  2024cites this paper
• A guide to RNA structure analysis and RNA‐targeting methods

  2024cites this paper
• Technologies for Targeted RNA Degradation and Induced RNA Decay

  2024cites this paper
• Small molecules modulating RNA splicing: a review of targets and future perspectives.

  2024cites this paper
• Splice-switching antisense oligonucleotides for pediatric neurological disorders

  2024cites this paper
• Therapeutic targeting of RNA for neurological and neuromuscular disease

  2024cites this paper
• splicekit: an integrative toolkit for splicing analysis from short-read RNA-seq

  2024cites this paper
• splicekit: a comprehensive toolkit for splicing analysis from short-read RNA-seq

  2023cites this paper
• Harnessing the necessary nitrogen atom in chemical biology and drug discovery

  2023cites this paper
• Small-molecule Ro-08-2750 interacts with many RNA-binding proteins and elicits MUSASHI2-independent phenotypes

  2023cites this paper
• Diverse targets of SMN2-directed splicing-modulating small molecule therapeutics for spinal muscular atrophy

  2023cites this paper
• Human disease models in drug development

  2023cites this paper
• DNA‐Encoded Libraries and Their Application to RNA

  2023cites this paper
• Interaction between a fluoroquinolone derivative KG022 and RNAs: Effect of base pairs 3′ adjacent to the bulged residues

  2023cites this paper
• The pyridazine heterocycle in molecular recognition and drug discovery

  2023cites this paper
• Neurofilament Light Chain: A Translational Safety Biomarker for Drug-Induced Peripheral Neurotoxicity

  2023cites this paper
• The diversity of splicing modifiers acting on A-1 bulged 5’-splice sites reveals rules to guide rational design

  2023cites this paper
• Remodeling oncogenic transcriptomes by small molecules targeting NONO

  2023cites this paper
• Pre-mRNA splicing-associated diseases and therapies

  2023cites this paper
• Recognizing the power of machine learning and other computational methods to accelerate progress in small molecule targeting of RNA

  2023cites this paper
• Targeting RNA with small molecules: lessons learned from Xist RNA

  2023cites this paper
• Contemporary Progress and Opportunities in RNA-Targeted Drug Discovery.

  2023cites this paper
• Reproductive findings in male animals exposed to selective survival of motor neuron-2 (SMN2) gene splicing modifying agents.

  2023cites this paper
• Cardiac splicing as a diagnostic and therapeutic target

  2023cites this paper
• Targeting RNA with small molecules—A safety perspective

  2023cites this paper
• Development of an oral treatment that rescues gait ataxia and retinal degeneration in a phenotypic mouse model of familial dysautonomia

  2023cites this paper
• It's ok to be outnumbered - sub-stoichiometric modulation of homomeric protein complexes.

  2023cites this paper
• Using the structural diversity of RNA: protein interfaces to selectively target RNA with small molecules in cells: methods and perspectives

  2023cites this paper
• SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy

  2023cites this paper
• Modulation of prion protein expression through cryptic splice site manipulation

  2023cites this paper
• Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington's Disease.

  2023cites this paper
• Identification of two short peptide motifs from serine/arginine-rich protein ribonucleic acid recognition motif-1 domain acting as splicing regulators

  2023cites this paper
• Spinal Muscular Atrophy, Approved Therapies and Future Prospects

  2023cites this paper
• RNA splicing modulator induces peripheral neuropathy with increased neurofilament light chain levels via p53 signaling

  2023cites this paper
• How does precursor RNA structure influence RNA processing and gene expression?

  2023cites this paper
• mRNA 3’UTR lengthening by alternative polyadenylation attenuates inflammatory responses and correlates with virulence of Influenza A virus

  2023cites this paper
• Molecular basis of RNA-binding and autoregulation by the cancer-associated splicing factor RBM39

  2023cites this paper
• Molecular Pathogenesis and New Therapeutic Dimensions for Spinal Muscular Atrophy

  2022cites this paper
• A meditation on accelerating the development of small molecule medicines targeting RNA

  2022cites this paper